Intervention not reported
Aldosterone antagonists plus loop diuretics plus albumin (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics plus albumin (No direct… (very low certainty).
1 finding from 1 review
HR 1.06 [0.57, 2.16]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus loop diuretics plus peritoneovenous shunt (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics plus peritoneovenous… (very low certainty).
1 finding from 1 review
HR 0.97 [0.4, 2.43]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus loop diuretics plus systemic vasoconstrictors (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics plus systemic… (very low certainty).
1 finding from 1 review
HR 0.42 [0.15, 1.22]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists (No direct RCT) (very low certainty).
1 finding from 1 review
HR 1.92 [0.24, 20.64]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus loop diuretics plus systemic vasoconstrictors plus paracentesis plus fluid replacement (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics plus systemic… (very low certainty).
1 finding from 1 review
HR 1.11 [0.02, 39.77]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus loop diuretics plus systemic vasoconstrictors plus systemic vasodilator (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics plus systemic… (very low certainty).
1 finding from 1 review
HR 0.61 [0.02, 9.17]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus loop diuretics plus systemic vasodilator (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics plus systemic… (very low certainty).
1 finding from 1 review
HR 0.62 [0.03, 9.1]
Studies not reported
Very low
Intervention not reported
Systemic vasoconstrictors plus albumin (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes systemic vasoconstrictors plus albumin (No direct RCT) (very low certainty).
1 finding from 1 review
HR 2.62 [0.41, 19.28]
Studies not reported
Very low
Intervention not reported
Serious adverse events (number of people) · people with liver cirrhosis and ascites
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Aldosterone antagonists plus loop diuretics (1 RCT; 41 participants) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics (1 RCT; 41 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Paracentesis plus fluid replacement · people with liver cirrhosis and ascites
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Transjugular intrahepatic portosystemic shunt (1 RCT; 70 participants) · people with liver cirrhosis and ascites
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Health‐related quality of life · people with liver cirrhosis and ascites
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Paracentesis plus systemic vasoconstrictors (4 RCTs; 145 participants) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes paracentesis plus systemic vasoconstrictors (4 RCTs; 145 participants) (very low certainty).
1 finding from 1 review
OR 1.63 [0.3, 11.66]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus loop diuretics (2 RCT; 84 participants) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics (2 RCT; 84 participants) (very low certainty).
1 finding from 1 review
OR 3.54 [0.43, 27.41]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus loop diuretics (1 RCT; 31 participants) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics (1 RCT; 31 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Paracentesis plus systemic vasoconstrictors (1 RCT; 25 participants) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes paracentesis plus systemic vasoconstrictors (1 RCT; 25 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Transjugular intrahepatic portosystemic shunt (6 RCTs; 427 participants) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes transjugular intrahepatic portosystemic shunt (6 RCTs; 427… (very low certainty).
1 finding from 1 review
HR 0.87 [0.52, 1.44]
Studies not reported
Very low
Intervention not reported
Symptomatic resolution of ascites at maximal · people with liver cirrhosis and ascites
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Aldosterone antagonists plus loop diuretics (3 RCTs; 125 participants) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics (3 RCTs; 125 participants) (very low certainty).
1 finding from 1 review
HR 1.1 [0.12, 10.74]
Studies not reported
Very low